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Abstract
Background: The importance of non-coding RNAs (ncRNAs) as fine regulators of eukaryotic gene expression has
emerged by several studies focusing on microRNAs (miRNAs). miRNAs represent a newly discovered family of non
coding-RNAs. They are thought to be crucial players of human hematopoiesis and related tumorigenesis and to
represent a potential tool to detect the early stages of cancer. More recently, the expression regulation of
numerous long ncRNAs has been linked to cell growth, differentiation and cancer although the molecular
mechanism of their function is still unknown.
NB4 cells are promyelocytic cells that can be induced to differentiation upon retinoic acid (ATRA) treatment and
represent a feasible model to study changes of non coding RNAs expression between cancer cells and their term-
inally differentiated counterpart.
Findings: we screened, by microarray analysis, the expression of 243 miRNAs and 492 human genes transcribing
for putative long ncRNAs different from miRNAs in NB4 cells before and after ATRA induced differentiation. Our
data show that 8 miRNAs, and 58 long ncRNAs were deregulated by ATRA induced NB4 differentiation.
Conclusion: our data suggest that ATRA-induced differentiation lead to deregulation of a large number of the
ncRNAs that can play regulatory roles in both tumorigenesis and differentiation.
Background
The past few years have revealed that the genomes of all
studied eukaryotes are almost entirely transcribed, gen-
erating an enormous number of long and small non-
protein-coding RNAs (ncRNAs) [1-5]. In parallel, it is
increasingly evident that many of these ncRNAs have
regulatory functions.
Considerable work has been done on small regulatory
RNAs. By miRNA microarray analysis, several labora-
tories have performed the miRNA expression profile
(miRNome) in cancer patients and found that miRNAs
are differentially expressed in normal and tumor tissues
[5-7]. These differences are often tumor-specific and,
potentially, can be related to diagnosis and prognosis.
In addition to these small ncRNAs, there are thou-
sands of longer transcripts whose functions are still
unknown [1,8-10]. Very recently, they have been func-
tionally linked to cancer and cell differentiation. Long
ncRNAs, such as H19 and BIC, can exert multiple func-
tions. Indeed, H19 long ncRNA promotes breast cancer
cell proliferation through positive control of E2F1 [11]
and can be processed into smaller RNA sequences hav-
ing the feature of miRNA [12]. The longer transcript
BIC originates miR-155, shown to be important in the
hematopoietic function [13] as well as in the homeosta-
sis and function of the immune system [14]. These
examples confirm the idea that also long ncRNAs can
play a role in cell transformation and differentiation.
NB4 is a promyelocytic cell line derived from the per-
ipheral blood of a M3 subtype Acute Promyelocytic
Leukemia (APL) patient [15]. Treatment with all-trans-
retinoic acid (ATRA) is able to revert the dominant-
negative effect of PML-RARa fusion protein and induce
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feasible model to study changes of ncRNAs expression
between cancer cells and their terminally differentiated
counterpart. While miRNAs have been implied in NB4
differentiation and tumorigenesis, there is a lack of
knowledge about the expression and function of other
families of ncRNAs. Fazi and co-workers showed that
upregulation of miR-223 lead to repression of NF1-A
translation and this is relevant in the early stages of
myeloid differentiation [17]. Garzon et al. [18] showed
by microarray analysis, that several miRNAs are sub-
jected to changes in the expression profile during ATRA
induced myeloid differentiation of promyelocytic cells.
In this work we used Ribochips to verify the expres-
sion profile of 243 miRNAs and 492 long ncRNAs, dur-
ing ATRA induced differentiation. We found 8 miRNAs
and 58 long ncRNAs whose expression levels changed
during differentiation. Our work indicates that a wide
variety of ncRNAs is regulated during differentiation
and suggests their involvement in cell differentiation
and tumorigenesis.
Methods
Chemicals
All chemicals were purchased from Sigma. All Trans
Retinoic Acid (ATRA) was dissolved in ethanol at a con-
centration of 1 mM stock solution and used at 0.5 μM.
Cell culture
Cells were cultured in RPMI 1640 medium supplemen-
ted with 10% foetal calf serum (FCS), 2 mM L-Gluta-
mine in 5% CO2 atmosphere. Both NB4 and HL60 cell
lines (2 × 10
5 cells/ml) were treated with 0.5 μM ATRA.
Differentiation was evaluated following the expression of
the antigen CD11c and CD11b by cytofluorimetry. Cell
viability was assayed by cytofluorimetry evaluating the
incorporation of propidium iodine into the dead cells.
RNA extraction
At various time after ATRA treatment, 1 × 10
7 cells
were collected and washed in PBS. Total RNAs were
extracted using TRIzol RNA extraction system (Invitro-
gene) according to the manufacturer’s instruction. The
integrity of the extracted RNA was assayed by 1% agar-
ose denaturing gel electrophoresis. The ribosomal RNA
28S and 18S were considered for assessing the integrity
of the total RNA.
Northern blot analysis
All RNA samples were dissolved in loading buffer
(0.05% bromophenol blue, 0.05% cyanol xilene, 5% Ficoll
(type 400), 80% formamide and 7 M urea), boiled for 5’
and loaded onto 15% polyacrylamide denaturing gel
(15% acrylamyde-bis-acrylamide 19/1, 45 mM Tris, 45
mM boric acid, 1 mM EDTA pH 8, 7 M urea, 0.01%
TEMED and 0.1% Ammonium persulphate). Samples
were resolved by electrophoresis (90’ at 150 V) and
transferred on nylon membrane (Hybond N
+,A m e r -
sham) by capillary blot. The membranes, equilibrated in
1 M NaCl, were pre-hybridized in 6× SSC, 5× Denhart’s
(0.1% Ficoll, 0.1% polyvinyl pirrolydone, 0.1% Bovine
Serum Albumin), 100 μg/ml of sheared salmon sperm
dsDNA (Ambion) at 42°C for 2 hr. 1 × 10
6 CPM/ml of
[g
32P-ATP] radiolabelled probe was added and the
hybridization carried over night at 42°C. The mem-
branes were washed twice in 2× SSC at 42°C for 30’ and
exposed either by autoradiography or by phosphorimage
screen (Amersham). Quantification of the related signals
was performed by image-scanning or Image-J software
analysis.
Real Time PCR
Primers were designed (sequences are available in the
additional files) for the following genes randomly
selected between those found significantly expressed in
cancer cell lines: THC1225071, AK021516,
NR_002196_H19, AK022994, AK092435, AK128567,
AK027352, AK097934, AL122122, CR593144,
THC1242508. The microarray expression data was vali-
dated by real-time quantitative PCR using the Platinum
SYBR Green qPCR SuperMix containing uracil DNA
glycosylase (UDG) (Invitrogen) according to manufac-
turer instructions after cDNA synthesis with SuperScript
III First-Strand Synthesis System for RT-PCR. Briefly 44
μl Master mix containing all of the reaction components
except the primers was dispensed into a 96-well real-
time PCR plate (Applied Biosystems) using a 8-channel
pipette. The master mix contained 1.5 U Platinum Taq
DNA polymerase, 20 mM Tris-HCl (pH 8.4), 50 mM
KCl, 3 mM MgCl2,2 0 0μMd N T P ,1μl UDG and water
to 44 μl. All the PCR reagents were from the SYBR
green core reagent kit (Invitrogen). A 10 μM solution of
each pair of primers was stored in 8-well PCR strip
tubes. Each primer (1 μl) was dispensed into duplicate
wells of the 96-well plate using the 8-channel pipette.
Real-time PCR was performed on an Applied Biosystems
7500 real-time PCR instrument equipped with a 96-well
reaction block. PCR was performed for 2 min at 50°C
and 2 min at 95°C for one cycle. Then 95°C for 15 s,
64°C for 30 s and 72°C for 35 s for 45 cycles followed
by the thermal denaturation protocol. Two normalised
human pooled tissue total RNA (Stratagene) were used
for comparison. Briefly, we used human normal tissue
from brain (stratagene cat. N. 540006) and from testis
(stratagene cat. N. 540050). The two samples were
pooled and used as control RNA. Relative quantifica-
tions were performed by determining the threshold
value as by ABI. All data were normalised to actin
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lysis in treated vs. untreated cells was performed as fol-
lows: the ΔCt value was calculated by subtracting the Ct
value of the non-coding RNA from the Ct value of
actin. The ΔΔCt value was calculated by subtracting the
ΔCt value for the untreated cell from to the ΔCt value
of the treated cells. Fold of enrichment values were
determined according to the following formula: 2
-ΔΔCT.
In additional files 1 and 2 the comparative non-coding
RNA expression analysis in cancer cells vs. human nor-
mal tissue (control in the graphs) was performed as fol-
lows: the ΔCt value was calculated by subtracting the Ct
value of the non-coding RNA from the Ct value of
actin. The ΔΔCt value was calculated by subtracting the
ΔCt value for the human normal tissue from to the ΔCt
value of the cancer cells Fold of enrichment values were
determined according to the following formula: 2
-ΔΔCT.
Details about the long ncRNAs Array Fabrication,
Fluorescent Labeling, Hybridization, Image Analysis and
Data Collection and Western blot are described in the
additional file 3.
Results and Discussion
miRNAs expression profile in ATRA treated NB4 cells
We compared the miRNA expression profile of termin-
ally differentiated neutrophils, NB4 ATRA treated [addi-
tional file 4], and untreated NB4 cells. In order to
increase the significance of the microarray analysis we
hybridised the RNA derived from two independent
experiments. The statistical analysis (Welch t-test and
SAM) identified 8 miRNAs differentially expressed
(Table 1), 72 miRNAs equally expressed before and after
treatment [additional file 5] and 163 miRNAs expressed
within the background, hence considered as unex-
pressed. In detail, the expression of miR-186, miR-215
and miR-223 resulted upregulated in ATRA differen-
tiated cells, while the expression of miR-17-5p, miR-25,
miR-193, miR-195,a n dlet-7a resulted downregulated
(the miRNAs bolded were already reported as deregu-
lated by ATRA in differentiated NB4 cells in refs. 17
and 18). The cluster analysis, derived from two indepen-
dent experiments for the 8 human miRNAs is shown in
figure 1A.
miR-17-5p and miR-25 are downregulated in NB4 cells
differentiated upon ATRA treatment
The microarray data indicated a strong downregulation
of miR-17 and miR-25 in the differentiated phenotype
(Figure 1B and 1C, NB4 lanes UT vs. T), two miRNAs
not yet described as deregulated during ATRA induced
differentiation of NB4 cells. Thus we focalized our ana-
lysis on them. We confirmed the microarray data by
Northern blot, using as DNA probes the antisense
mature sequence of both deregulated miRNA. All north-
ern blots were normalized against U6 snRNA. The den-
sitometric analysis, carried out on three independent
experiments, showed that in ATRA treated NB4 cells
the expression of miR-17 decreased about 6 fold while
the expression of miR-25 decreased about 4 fold. These
results were confirmed also in HL60 cells, (Figure 1B
and 1C, HL60 lanes UT vs. T) another promyelocytic
cell line inducible to granulocyte differentiation by reti-
noids. In both cell lines we observed a proportional cor-
relation between the amount of the mature miR-17 and
its precursor suggesting that this miRNA is mainly regu-
lated at transcriptional level during myeloid differentia-
tion. As positive control we checked for the expression
of miR-223, upregulated during myeloid differentiation
[17]. As expected, miR-223 was found expressed 10 fold
higher after ATRA induced differentiation (Figure 1D)
in both NB4 and HL60 cells.
By in silico analysis we found that both miR-25 and
miR-17 could have as putative targets E2F1 and E2F4,
thus, they could synergistically act in the control of pro-
myelocytic proliferation and differentiation. To test our
hypothesis we analyzed the expression level of E2F1 and
E2F4 proteins in untreated and ATRA differentiated
NB4 cells. As shown in additional file 6, both the pro-
teins as well as the two miRNAs were downregulated by
ATRA differentiation. These results would suggest that
Table 1 miRNAs with altered expression after ATRA induced differentation in NB4 cells by microarray analysis.
Name P-value NB4 expression NB4 + ATRA expression Map TvsUT Validation Densitometry
hsa-mir-017-precNo2 0,0447 2,944 1,388 13q31 Down down 6.0 fold
hsa-mir-186-prec 0,0447 0,864 0,891 1p31 Up up 0.5 fold
hsa-mir-193-precNo1 0,0385 1,031 0,847 17q11.2 Down down 1.2 fold
hsa-mir-195-prec 0,0373 2,618 1,954 17p13 Down down 0.8 fold
hsa-mir-025-prec 0,0351 7,56 3,157 7q22 Down down 4.1 fold
hsa-let-7a-1-prec 0,0243 0,962 0,889 9q22.2 Down up 3.2 fold
hsa-mir-215-precNo2 0,0104 0,691 0,792 1q41 Up up 0.5 fold
hsa-mir-223-prec 0.0232 8.68 17.08 Xq12-13.3 Up up 10.6 fold
In the table are showed for each miRNA the name (hsa = human miRNAs), the P-value, the normalization of two independent experiment (NB4 = untreated;
NB4-ATRA = treated); the locus map (map); the expression in treated versus untreated cells (T vs UT) and the expression (T vs UT) after northen blot validation
(validation: up = upregulation; down = downregulation); the densitometry shows the average of three independent experiments.
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factors, in NB4 cells from Acute Promyelocytic Leuke-
mia. For this reasons, further studies on the identifica-
tion of genes possessing miR-17-5p or miR-25
complementary sequences are required.
The relevance of miR-223 upregulation during the
early stages of myeloid differentiation has been
described [17]. We observed a ten-fold upregulation of
miR-223 expression in our system, when the CD11
+
positive cells are more than 90%, hence terminally dif-
ferentiated [additional file 4]. Thus, miR-233 may repre-
sent not only an early factor required for myeloid
differentiation but it could play an additional important
role in the maintenance of the differentiated phenotype.
Long non-protein coding RNAs are deregulated during
ATRA differentiation of NB4 cells
DNA array hybridisation experiments were performed to
compare the expression levels of 492 ncRNA genes in
NB4 versus NB4 + ATRA treated cells. Fifty-eight genes
were found deregulated (Figure 2A), 144 genes equally
expressed in both NB4 phenotypes and 290 expressed
within the background, hence considered as unexpressed.
Among the 58 deregulated genes eleven randomly chosen
were validated by Real Time PCR (Figure 2B). The statis-
tical analysis was performed with Prism v4.0 (GraphPad
software).
The variation in the expression of the detected
ncRNAs in both NB4 cells phenotypes was analyzed and
compared to their expression in several cancer cell lines.
In additional file 1 and 2 is shown the Real Time analy-
sis in cancer cell lines of twelve deregulate ncRNAs as
an example. This analysis allowed us to validate the
ontogeny groups assigned through differential expres-
sion in proliferating versus differentiated NB4 cells.
The group of deregulated genes, represented by
AK092435, AK130351, AK131003, BC035189,
AK023690, AK097380, AK098425 AK128567 and
AL110204 was found upregulated by ATRA-induced dif-
ferentiation in NB4 cells (Figure 2A). All these genes,
highly expressed in cancer cells (data not shown), may
therefore be considered as genes not involved in
Figure 1 Cluster analysis of treated and untreated NB4 cell lines using the 8 human miRNAs differentially expressed and Northern
blot validation of miR-223, miR-17 and miR-25. A) Cluster analysis, made only for the human miRNAs, reveals that the 8 miRNAs changed
their expression after treatment. In fact, red color means that the expression of the miR is higher in NB4 cell line treated with ATRA while green
color means that the expression is lower. Yellow means no variation. B, C, D) 15 μg of total RNA was loaded in each lane from two independent
experiments. The membranes were probed as indicated on the side: B) miR- 17 probe and U6 snRNA probe; C) miR-25 probe and U6 snRNA
probe; D) miR- 223 probe and U6 snRNA probe. Note that for the miR-17 is visualized also the precursor (prec. miR-17). T = 6 days of 0.5 mM
ATRA treatment, UT = untreated.
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result from the activity of transcription factors regulated
by ATRA signalling, as NF-k-B, C/EBP-a,C / E B P - b or
C/EBP-ε. A second group of transcripts found overex-
pressed in cancer cell lines and downregulated in
ATRA-differentiated NB4 cells is represented by
AK025078 (SLC26A2), AK027179, AK055935,
AK125234 and BC030949, a gene potentially involved in
the juvenile leukaemia. These genes are potentially
linked to proliferation and they could be upregulated
through myc and ras signalling pathway, activated in
proliferating NB4 cells [19].
AK001558, a gene upregulated in human retinal Muller
cells and protecting against oxidative stress [20], was found
expressed in cancer cell lines but showed similar expres-
sion in both proliferating and differentiated NB4 cells (data
not shown). In addition to ncRNAs distributed randomly
onto all chromosomes the Ribochip contained 70 tran-
scripts from the chromosome 7, to analyse their expression
changes associated to the transcripitonal state of the
HOXA locus. Although most of these transcripts did not
show significant variations, untreated NB4 cells showed
several upregulated genes, as 7p21 (GA 3603), downstream
of HOXA gene cluster, while after differentiation we found
Figure 2 Long non-protein coding RNAs are deregulated during ATRA differentiation of NB4 cells. A) In the table are showed the 58
ncRNAs found deregulated in ATRA treated NB4 cells. Asterisks indicate the ncRNAs validate by quantitative real-time PCR. B) Real time
confirmed the microarray data. The experiments, performed three times, are shown as fold induction of ATRA NB4 vs. untreated NB4 (UT). The
bars indicates ± SEM. Statistical analysis was performed with Prism v4.0 (GraphPad software); asterisk indicate significant differences between
ATRA treated NB4 and UT NB4 according to the two-tailed unpaired Student’s t test (*, P < 0.05). The primer sequences, used for the real time
PCR are shown in the supplementary file 3.
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GA3749 in 7p13 and AK026119 in 7p14.
Finally, H19 is overexpressed in some types of cancers
[12] and it was found expressed at highest levels in pro-
liferating NB4 cells (Figure 2B) and in tumor cell line
such as the ERBB2-overexpressing SKBR3 cell line
[additional files 1 and 2] and the 883KE testis cancer
cell line [additional files 1 and 2]. Thus H19 seems to
be involved in cell proliferation.
All together these data show that, even if the function of
long ncRNAs as tumor suppressors or as oncogenes can
be only hypothesized to date, their expression is related to
cell physiology and in some case is tumor specific.
In conclusion, this work shows that several ncRNAs
are potentially involved in proliferation and ATRA-
induced differentiation of NB4 cells. The association of
functional characterization of the studied genes with
their expression in cancer may provide clues on their
ontology class, and possibly on their function in the
aetiology of diseases. Moreover, the increasing number
of ncRNAs whose expression profile changes accord-
ingly to the cell phenotype (transformed or terminally
differentiated) could represent, in the near future, a sui-
table biomarker to characterize differentiation.
Additional file 1: Expression by Real time PCR of 15 ncRNAs in
cancer cell lines. RT-PCR of ncRNA expression data using the Ribochip
in different cancer cell lines, using primer pairs for selected genes
AF143872, AK022994, TCAG1963768, AK094435, THC1225071, AL122122,
THC1242508, AK128567, AK098425, H19, CR593144, AF143872, AK021516,
AK027352, AK097934, AK097482, randomly selected, and significantly
expressed in the cancer cell lines SKBR3, MCF-7, HS-578T (Breast cancer);
Be[2]C, CCF-STTG1, DAOY1, (Brain cancer); LS174-T, Caco-2, WiDr, SW1116
(Colon cancer), GLC-4, H226 (Lung cancer), 833KE, NT2, Tera-1 (Testis
cancer). As control we pooled human normal tissue total RNA from brain
and from testis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S1.PDF]
Additional file 2: Expression by Real time PCR of 15 ncRNAs in
cancer cell lines. See Additional file 1
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S2.PDF]
Additional file 3: Additional M&M information. Materials and Methods
for Array Fabrication, Fluorescent Labeling and Hybridization, Image
Analysis and Data Collection, Human genome bioinformatic analysis,
Microarray analysis, ATRA-induced differentiation of promyelocytic NB4
cells. Western blot analysis and Primers sequences for Real Time
validation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S3.DOC]
Additional file 4: Representative experiment of ATRA induced
differentiation of NB4 cells assayed by FACS analysis. A and B) CD11
+ FACS readout in NB4 untreated (A) or ATRA treated cells (B) using PE-
conjugated a-CD11c mAb; C and D) cell viability FACS readout in NB4
untreated (C) or ATRA treated cells (D) using propidium iodine.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S4.PDF]
Additional file 5: miRNAs equally expressed in both ATRA treated
and untreated NB4 cells by microarray analysis. Hsa = human
miRNAs; mmu = miRNAs
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S5.PDF]
Additional file 6: E2F1 and E2F4 proteins level don’t correlate with
the miR-25 and miR-17 expression in NB4+ ATRA treated cells.3 0
μg of total proteins were extracted at the indicated times from ATRA
treated (T) or untreated (UT) NB4 cells and analyzed by western blot
using a-E2F1 and a-E2F4 polyclonal antibodies (Santa Cruz). Input
proteins were equalized by detecting the endogenous g-tubulin.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-0500-3-24-
S6.PDF]
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